CTRI/2018/03/012303进行中（未招募）1 期
Clinical evaluation of the safety and efficacy of the investigational product containing herbal actives for hair growth and hair quality in subjects experiencing hair loss - NI
试验速览
- 阶段
- 1 期
- 状态
- 进行中（未招募）
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
入选标准
- •1.Male and female subjectsâ?? in general good health.
- •2.Subjects in the age group 18-45 years (both the ages inclusive).
- •3.Subjects willing to give a written informed consent and agree to come for a regular follow up visit.
- •4.Subjects with hair fall- above 20 hair fall in comb test (with bulb+ without bulb)
- •5.Subjects with follicular density above 100-200
- •6.Subjects complaining of hair fall
- •7.Subjects complaining about hair thinning
- •8.Subjects who have not participated in a similar investigation in the past three months.
- •9.Healthy volunteers with no known allergy as established by medical history.
- •10.Subjects who do not smoke or drink
- •11.Subjects who are not crash dieting.
- •12.Subjects who agree to refrain from using hair dye / hair color during the study period.
- •13.Subjects willing to refrain from any type of hair treatment like perming, straightening etc. during the study duration.
- •14.Subjects with regular oiling habits
排除标准
- •1.A known history or present condition of allergic response/hypersensitivity to any cosmetic ingredients and pharmaceutical products.
- •2.Subjects who have had hair transplant.
- •3.Subjects who take pharmaceutical product which cause hirsutism (ex. phenytoin) and finesteride for androgenic alopecia
- •4.Subjects who have undergone hair growth treatment within 3 months before screening into the study.
- •5.Subjects having any active scalp diseasewhichmayinterfere in the studydermatologistâ??sjudgement.
- •6.Subjects who have taken chemotherapy for cancer in the 6 months prior to start of the study or have a plan to do treatments during study.
- •7.Subjects who have history of alcoholism and/ or psychiatric disorder including trichotillomania.
- •8.Subjects consuming alcohol and smoking
- •9.Subjects on oral medications which will compromise the study.
- •10.Subjects who are pregnant or lactating or nursing as established with medical history.
- •11.Under medical treatment for hair problems
- •12.Undergoing any chemical hair salon treatment-
- •straightening / perming / colour
- •13.Menopausal female subjects as determined by medical history.
- •14.Pregnant female subjects as determined by UPT test
- •15.Chronic illness which may influence the cutaneous state. Subjects participating in other similar cosmetic or therapeutic trial within last three months
- •16.Any history of underlying uncontrolled medical illness including diabetes mellitus, hypertension, HIV, hepatitis, severe anemia, serious disorder of heart and respiratory apparatus or any other serious medical illness.
研究者
相似试验
已完成
不适用
Clinical evaluation of the efficacy and safety of Hochuekkito for fatigue in patients with myeloproliferative neoplasmsmyeloproliferative neoplasmsJPRN-UMIN000031519Department of Hematology, Juntendo University School of Medicine110
招募中
1 期
Clinical evaluation of the efficacy and safety of Huayu Tongbi Fomular on rheumatoid arthritisRheumatoid ArthritisITMCTR2024000092Guangdong Provincial Hospital of Chinese Medicine
已完成
3 期
Clinical evaluation of the safety and effectiveness of Excilor 2-in-1 Wart Treatment in the treatment of warts on the hands and feetISRCTN39469406Medical Brands66
未知
2 期
Clinical evaluation of the efficacy and safety of the guideline of oral ingestion of NaCl for children with ileostomyileostomyJPRN-UMIN000016711Division of Pediatric Surgery, Department of Surgery, Kobe University Graduate School of Medicine30
已完成
不适用
Clinical evaluation of the efficacy and safety of robot-assisted hysterectomy using da Vinci surgical system for benign gynecologic diseaseBenign gynecologic disease such as uterine myomas, adenomyosis, etc.JPRN-UMIN000040068Kitasato University Hospital5